Scleroderma in the Kidney

Dr. Christopher Denton, with the Royal Free and University Hospital in the UK, is an expert on renal complications in scleroderma. In this session he provides insights on its impact for scleroderma patients.

He is Professor of Experimental Rheumatology at UCL Medical School and Consultant Rheumatologist and Joint Director of the Centre for Rheumatology, Royal Free Hospital, London. Dr. Denton runs the largest scleroderma service in UK with more than 1,000 scleroderma patients and has published extensively on laboratory and clinical aspects of Raynaud’s phenomenon, connective tissue disease, and pulmonary hypertension.

A compassionate physician, he also finds time to lead the UK Scleroderma Study Group (UKSSG), serve as Treasurer of EUSTAR and serve as Chair of the Heberden Scientific Committee of the British Society for Rheumatology (BSR). Professor Denton has co-edited a major textbook of scleroderma and manages an expert team of nurses, doctors, and research fellows, including several previously supported by the Raynaud’s and Scleroderma Association.